Free US stock correlation to major indices and sector benchmarks for performance attribution analysis and return source identification. We help you understand how your portfolio moves relative to broader market benchmarks and identify return drivers. We provide correlation analysis, attribution breakdown, and benchmark comparison for comprehensive coverage. Understand performance drivers with our comprehensive correlation and attribution analysis tools for portfolio optimization.
Integra LifeSciences Holdings Corporation (IART) is a medtech firm focused on surgical and regenerative medicine products, whose shares are currently trading at $10.84 as of April 16, 2026, marking a 1.72% decline from its prior closing price. This analysis breaks down key technical levels, recent market context for the stock, and potential short-term scenarios for traders and investors to monitor. No recent earnings data is available for IART as of this writing, so price action has been driven
Integra (IART) Stock Relative Weakness (Institutional Selling) 2026-04-16 - Most Watched Stocks
IART - Stock Analysis
3743 Comments
874 Likes
1
Tiffiany
New Visitor
2 hours ago
This feels like a secret but no one told me.
👍 162
Reply
2
Anisa
Active Contributor
5 hours ago
Mindfully executed and impressive.
👍 108
Reply
3
Archith
Senior Contributor
1 day ago
That’s pure artistry. 🎨
👍 285
Reply
4
Maelynn
Returning User
1 day ago
Positive breadth suggests multiple sectors are participating in the rally.
👍 104
Reply
5
Bintu
Engaged Reader
2 days ago
Nothing but admiration for this effort.
👍 20
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.